Objectives

After participating in this educational activity, attendees should be able to:
1| Identify the best candidates for lung cancer screening.
2| Assess the value of interventions to improve lung cancer outcomes equity.
3| Determine the best treatments for early stage lung cancer.

Faculty

Juan Wisnivesky, MD, DrPH
Professor with Tenure, Department of Medicine
Mount Sinai Health System
Icahn School of Medicine at Mount Sinai, New York

Faculty Disclosure

Baystate Health Continuing Interprofessional Education follows the ACCME Standards for Integrity and Independence in Accredited Continuing Education.  The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity

Dr. Wisnivesky is a consultant for Sanofi, Atea, Bannok, Prospero and receives grants from Sanofi, Regeneron, Arnold Consultant, Axella.

None of the planners for this educational event have commercial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

                                                                             



Accreditation Statement
In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physicians
Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Physician Assistants

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.  Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.  This activity is designated for 1.0 AAPA Category 1 CME credits.  PA’s should only claim credit commensurate with the extent of their participation. 

Risk Management

This activity meets the criteria for risk management study. 1.0 hours are appropriate for risk management study.


This activity was planned by and for the healthcare team and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Session date: 
03/10/2023 - 12:00pm to 1:00pm EST
Location: 
Hybrid / Chesnut 1A&B (lunch to be provided)
Baystate Medical Center
759 Chestnut St
Springfield, MA 01199
United States
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BCIPE Risk Management
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.